Evaluating the efficacy and safety of rivaroxaban as a warfarin alternative in chronic thromboembolic pulmonary hypertension patients undergoing pulmonary endarterectomy: A randomized clinical trial

Evaluating the efficacy and safety of rivaroxaban as a warfarin alternative in chronic thromboembolic pulmonary hypertension patients undergoing pulmonary endarterectomy: A randomized clinical trial

Background and aim: Chronic thromboembolic pulmonary hypertension (CTEPH) is caused by the obstruction of the main pulmonary artery due to thrombosis and vascular remodeling. Regarding the need for anticoagulant therapy in CTEPH patients, this study aimed to compare rivaroxaban with warfarin in term...

Full description

Bibliographic Details
Main Authors: Saghar Barati, Hossein Amini, Zargham Hossein Ahmadi, Alireza Dastan, Babak Sharif Kashani, Raha Eskandari, Farzaneh Dastan
Format: Article
Language:English
Published: Elsevier 2023-02-01
Series:Revista Portuguesa de Cardiologia
Subjects:
Hipertensão pulmonar tromboembólica crónica
Rivaroxabano
Varfarina
Endarterectomia
Cirurgia
Online Access:http://www.sciencedirect.com/science/article/pii/S0870255122004589

Internet

http://www.sciencedirect.com/science/article/pii/S0870255122004589

Similar Items